EBNA-1 AND BZLF1 PLUS IGG SERUM LEVELS INDIVIDUATE EARLY STAGES OF EPSTEIN-BARR-VIRUS (EBV)-RELATED POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) AND HELPS MODULATION OF IMMUNE SUPPRESSION (IS) IN LIVER-TRANSPLANT RECIPIENTS
F. Migliaro et al., EBNA-1 AND BZLF1 PLUS IGG SERUM LEVELS INDIVIDUATE EARLY STAGES OF EPSTEIN-BARR-VIRUS (EBV)-RELATED POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) AND HELPS MODULATION OF IMMUNE SUPPRESSION (IS) IN LIVER-TRANSPLANT RECIPIENTS, Hepatology, 28(4), 1998, pp. 423-423